Product Images Propafenone Hydrochloride

This is a graph representing the proportion of patients without an event over time. The patients were treated with either Propafenone ER or placebo. There were a total of 307 patients in the study, with varying dosages of Propafenone ER. One patient had an event on day 231 which resulted in a 50% decline in the Kaplan-Meier curves. The study lasted for 300 days.*

This is a medication label with instructions for use and dosage information. The medication is available in capsule form, with a recommended dosage of one capsule every 12 hours. The label warns against accepting a bottle with a broken seal and emphasizes the need to keep the drug out of the reach of children. The label also provides storage instructions and contact information for the pharmaceutical company that distributes the medication. Additionally, there is an image of a non-printing dieline with a non-varnished area and a corner radius of 125 inches.*

This is a label size description with dimensions of 17/8" x 5 5/8" (B size). There is also a non-printing dieline present. The text includes information about a capsule containing Froptenon yiucnone and its recommended dosage. Additionally, it provides information about the storage temperature and cautions the reader to keep the capsules out of reach of children. Lastly, it notes the manufacturer and includes some dimensions for the label.*

This is a label for Propafenone Hydrochloride Extended Release capsules. The label size is 3 12 x 7" (D size) and has a non-printing area. The capsules should be taken every 12 hours and contain 225mg. The manufacturer is Sennmomngeren S strides Pharma Inc. The container has 500 capsules and is available only by prescription.*

Label size 17/8" x5 5/8" (B size). Nonvarnished area. This document appears to be a prescription drug label with instructions for usage and storage indicated.*

This text is describing a label for Propafenone hydrochloride Extended Release capsules. It includes details such as the size of the non-printed dieline, non-vanished area, and dosage instructions. The capsules contain 325 mg of Propafenone hydrochloride, and the usual dosage is one capsule every 12 hours. The label also includes information on storing and dispensing the capsules, as well as the NDC and manufacturer information. There are also measurements provided for the size of the label corners.*

The text contains information about a label size of 3.5" x 7", non-printing dieline, non-varnished area, NDC code 64380-185-04 E, and Propafenone hydrochloride 325mg extended-release capsules. It also mentions typical dosage for the medicine and storage instructions. However, the text is not well-structured and some characters are missing, so the overall comprehension of the content is affected.*

This label size is 1 7/8" x 5 5/8" and is classified as B size. There is a nonvarnished area and a non-printing dieline included. The label contains information about ropafenone hydrochloride extended-release capsules. The recommended storage temperature for the capsules is 25°C (77°F) and excursions are permitted to 15-30°C (59-86°F). This label also includes a measurement of 125" radius and dimensions of 5 5/8" for the length along with a corner.*

Label size is 1 7/8" x 5 5/8" (B size). The label contains instructions and information regarding the dosage of a drug and its accompanying prescribing format. It also cautions against accepting damaged or broken capsules and recommends storage below 25°C. The label is produced by Strides Pharma Inc.*

This is a drug label for Propafenone Hydrochloride Extended Release Capsules, with a size of 3 1/2" x 7" and containing 425 mg. Its usual dosage is one capsule every 12 hours. The label also includes storage instructions and a warning to keep it out of reach of children. The label is distributed by Strides Pharma and has an NDC number of 64380-186-04. Additional information regarding the file could not be read.*